Xylogenics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $525K

Xylogenics General Information

Description

Operator of a yeast genomics company intended to redefine fermentation through synthetic biology. The company has developed multiple value-added organisms for fuel ethanol fermentation and the production of specialty chemicals and is trialing an innovative yeast product in the fuel ethanol market leveraging its proprietary protein expression platform for other high-value bio-based production markets, it uses molecular biology techniques to create novel biocatalysts for more efficient production of high-value chemicals, protein therapeutics, and biofuels, enabling farmers, home brewers, and innovators to accelerate fermentation and increase yields.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Corporate Office
  • 606 West Main Street Suite A
  • Suite 606 A
  • Pittsboro, IN 46167
  • United States
+1 (317) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xylogenics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 20-Dec-2010 $525K Completed Startup
To view Xylogenics’s complete valuation and funding history, request access »

Xylogenics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a yeast genomics company intended to redefine fermentation through synthetic biology. The company has develo
Biotechnology
Pittsboro, IN
8 As of 2023
0000000000

000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
0000000000000
Bagsvaerd, Denmark
0000 As of 0000
00000000

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
000000000000000
Teaneck, NJ
0000 As of 0000
00.000
000000000 00 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Xylogenics Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novozymes Corporation Bagsvaerd, Denmark 0000 00000000
Phibro Animal Health Formerly PE-Backed Teaneck, NJ 0000 00.000 000000000 00 00.000
Cte Global Corporation Northbrook, IL 000000000 -
Ferm Solutions Corporation Danville, KY 00
Lallemand Corporation Montreal, Canada 0000
To view Xylogenics’s complete competitors history, request access »

Xylogenics Patents

Xylogenics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3225830-A1 Strains of saccharomyces cerevisiae that exhibit an increased ability to ferment oligosaccharides into ethanol without supplemental glucoamylase and methods of making and using the sam Pending 12-Jul-2021 000000000
US-20210309982-A1 Materials and methods for creating strains of saccharomyces cerevisiae that exhibit an increased ability to ferment oligosaccharides into ethanol Pending 19-Jul-2018 0000000000
EP-3824072-A1 Materials and methods for creating strains of saccharomyces cerevisiae that exhibit an increased ability to ferment oligosaccharides Pending 19-Jul-2018 0000000000
CA-3147863-A1 Materials and methods for creating strains of saccharomyces cerevisiae that exhibit an increased ability to ferment oligosaccharides Pending 19-Jul-2018 0000000000
EP-3824072-A4 Materials and methods for creating strains of saccharomyces cerevisiae that exhibit an increased ability to ferment oligosaccharides Pending 19-Jul-2018 C12N9/2402 0
To view Xylogenics’s complete patent history, request access »

Xylogenics Executive Team (7)

Name Title Board Seat Contact Info
Joshua Heyen Ph.D Founder, Chief Executive Officer, President & Board Member
Ross Cocklin Co-Founder & Director of Systems Biology
Cary Woods Co-Founder
Mark Goebl Ph.D Co-Founder, Chief Scientific Advisor and Board Member
You’re viewing 4 of 7 executive team members. Get the full list »

Xylogenics Board Members (8)

Name Representing Role Since
Bruno Casadei Self Board Member 000 0000
Connie Houin Self Chairman 000 0000
James Miller Self Board Member 000 0000
John Didion Self Board Member 000 0000
Joshua Heyen Ph.D Xylogenics Founder, Chief Executive Officer, President & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Xylogenics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xylogenics FAQs

  • When was Xylogenics founded?

    Xylogenics was founded in 2008.

  • Who is the founder of Xylogenics?

    Joshua Heyen Ph.D, Ross Cocklin, Cary Woods, Mark Goebl Ph.D, and Mike Neibler are the founders of Xylogenics.

  • Who is the CEO of Xylogenics?

    Joshua Heyen Ph.D is the CEO of Xylogenics.

  • Where is Xylogenics headquartered?

    Xylogenics is headquartered in Pittsboro, IN.

  • What is the size of Xylogenics?

    Xylogenics has 8 total employees.

  • What industry is Xylogenics in?

    Xylogenics’s primary industry is Biotechnology.

  • Is Xylogenics a private or public company?

    Xylogenics is a Private company.

  • What is Xylogenics’s current revenue?

    The current revenue for Xylogenics is 000000.

  • Who are Xylogenics’s competitors?

    Novozymes, Phibro Animal Health, Cte Global, Ferm Solutions, and Lallemand are some of the 6 competitors of Xylogenics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »